Login to Your Account

Galera's Small-Molecule Shields to Protect Against Superoxide

By Jennifer Boggs
Managing Editor

Friday, December 28, 2012
Galera Therapeutics Inc., a 2009 start-up based on the approach of treating disease by targeting superoxide, came out of stealth mode in December with a new CEO and a Series A financing of $11 million.

To continue reading subscribe now to Latest News

Learn More about Latest News

Already a subscriber? Sign In or Buy now to activate your subscription